Latest news with #CarbamazepineExtended-Release
Economic Times
28-07-2025
- Business
- Economic Times
Stocks in news: IndusInd Bank, Adani Green, Kotak Bank, NTPC Green, Ola Electric
Tata Chemicals reported a sharp 68% year-on-year rise in consolidated net profit for the quarter ended June 2025, with earnings climbing to Rs 252 crore. Indian markets closed lower for the fourth consecutive week amid mixed signals. Several companies like IndusInd Bank and Adani Green remained in focus due to Q1 results. IDFC First Bank, Kotak Mahindra Bank, and SBI Cards reported profit declines. Tata Chemicals saw a significant profit increase. Alembic Pharma received US FDA approval. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Markets ended lower for the fourth straight week as caution prevailed amid mixed cues. In today's trade, shares of IndusInd Bank Adani Green , Kotak Bank, NTPC Green Ola Electric among others will be in focus due to various news developments and first quarter Adani Green , IndusInd, Waaree Energies, Adani Total Gas, Mazagon Dock, RailTelShares of BEL, Adani Green, IndusInd, Waaree Energies, Adani Total Gas, Mazagon Dock and RailTel will be in focus as the companies will announce their first quarter results. IDFC First Bank has reported a 32% YoY decline in its profit after tax (PAT) at Rs 463 crore in the first quarter of the financial year 2026. Kotak Mahindra Bank reported a 47% year-on-year decline in its consolidated net profit for the June quarter at Rs 3,282 Green signed MoU with Bihar State Power Generation Company Limited (BSPGCL) for development of Battery Energy Storage Projects and Renewable Energy Project forAlembic Pharma received US FDA Final nod for Carbamazepine Extended-Release tablets, which are indicated for use as an Electric board approved proposed variation in the objects/terms of utilisation of the IPO proceeds and extension of time limit for utilisation of Cards reported a 6% year-on-year decline in net profit for the quarter ended June 2025, coming in at Rs 556 crore. Tata Chemicals reported a sharp 68% year-on-year rise in consolidated net profit for the quarter ended June 2025, with earnings climbing to Rs 252 crore.
Time of India
28-07-2025
- Business
- Time of India
Stocks in news: IndusInd Bank, Adani Green, Kotak Bank, NTPC Green, Ola Electric
Markets ended lower for the fourth straight week as caution prevailed amid mixed cues. In today's trade, shares of IndusInd Bank , Adani Green , Kotak Bank, NTPC Green , Ola Electric among others will be in focus due to various news developments and first quarter results. BEL, Adani Green , IndusInd, Waaree Energies, Adani Total Gas, Mazagon Dock, RailTel Explore courses from Top Institutes in Please select course: Select a Course Category MBA Digital Marketing healthcare Data Science Degree Product Management Operations Management Project Management Cybersecurity Technology Data Science Data Analytics Finance Design Thinking Healthcare Others MCA CXO others Leadership Management PGDM Public Policy Artificial Intelligence Skills you'll gain: Analytical Skills Financial Literacy Leadership and Management Skills Strategic Thinking Duration: 24 Months Vellore Institute of Technology VIT Online MBA Starts on Aug 14, 2024 Get Details Skills you'll gain: Financial Management Team Leadership & Collaboration Financial Reporting & Analysis Advocacy Strategies for Leadership Duration: 18 Months UMass Global Master of Business Administration (MBA) Starts on May 13, 2024 Get Details Shares of BEL, Adani Green, IndusInd, Waaree Energies, Adani Total Gas, Mazagon Dock and RailTel will be in focus as the companies will announce their first quarter results. IDFC First Bank IDFC First Bank has reported a 32% YoY decline in its profit after tax (PAT) at Rs 463 crore in the first quarter of the financial year 2026. Kotak Bank Kotak Mahindra Bank reported a 47% year-on-year decline in its consolidated net profit for the June quarter at Rs 3,282 crore. NTPC Green NTPC Green signed MoU with Bihar State Power Generation Company Limited (BSPGCL) for development of Battery Energy Storage Projects and Renewable Energy Project for Alembic Pharma Alembic Pharma received US FDA Final nod for Carbamazepine Extended-Release tablets, which are indicated for use as an anticonvulsant. Ola Electric Ola Electric board approved proposed variation in the objects/terms of utilisation of the IPO proceeds and extension of time limit for utilisation of proceeds. SBI Cards SBI Cards reported a 6% year-on-year decline in net profit for the quarter ended June 2025, coming in at Rs 556 crore. Tata Chemicals Tata Chemicals reported a sharp 68% year-on-year rise in consolidated net profit for the quarter ended June 2025, with earnings climbing to Rs 252 crore.
Business Standard
26-07-2025
- Business
- Business Standard
Alembic Pharmaceuticals receives USFDA approval for Carbamazepine Extended-Release Tablets
Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg, and 400 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Tegretol-XR Extended Release Tablets, 100 mg, 200 mg, and 400 mg, of Novartis Pharmaceuticals Corporation. Carbamazepine Extended-Release Tablets are indicated for use as an anticonvulsant drug and also for the treatment of the pain associated with true trigeminal neuralgia. Refer label for a detailed indication. Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg, and 400 mg, have an estimated market size of US$ 71 million for twelve months ending March 2025 according to IQVIA. Alembic has a cumulative total of 225 ANDA approvals (202 final approvals and 23 tentative approvals) from USFDA.
